Inovalon
- Enterprise Customers500FY, 2016
- Revenue$667.5 MFY, 2020
- Market Capitalization$3.1 B2021-11-12
OverviewSuggest Edit
Inovalon is a technology company which provides cloud-based platforms to the healthcare industry. Leveraging large-scale data interconnectivity capabilities, large proprietary data sets, advanced analytics, data-driven intervention systems, and deep subject matter expertise, the Company enables the assessment and improvement of clinical and quality outcomes and financial performance across the healthcare ecosystem.
| Type | Public | |
| Founded | 1998 | |
| HQ | Bowie, MD, US | Map |
| Website | inovalon.com | |
| Employee Ratings | ||
| Overall Culture | B+ | More |
Recent NewsAll News
- CorEvitas, LLC and Inovalon Highlight Data Linkage Efficiencies at ISPOR
- American Oncology Network Taps Inovalon to Support Efficient, Reliable Delivery of Oral Oncology Medications
- Pharmacare Hawaii Selects Inovalon to Ensure Best Clinical Outcomes for Specialty and Infusion Pharmacy Patients
- Inovalon Launches Registration Assurance Solution for Healthcare Providers
Key People/Management at Inovalon
Keith R. Dunleavy
Chief Executive Officer
Robert A. Wychulis
President
Eron S. Kelly
President
Beverly Allen
General Counsel, Chief Compliance and Privacy Officer
Jonathan Boldt
Chief Financial Officer
Matt Brow
President and General Manager, Pharmacy, Life Sciences, and Advisory
Inovalon Office Locations
Inovalon has offices in Bowie, Boston, Canonsburg, Minneapolis and in 4 other locations
Bowie, MD, US (HQ)
4321 Collington Rd
Boston, MA, US
399 Boylston St #350
Canonsburg, PA, US
275 Technology Dr #200
Minneapolis, MN, US
100 N 6th St #900A
Nashville, TN, US
443 Donelson Pike #200
Phoenix, AZ, US
4645 E Cotton Center Blvd #105
Inovalon Financials and Metrics
Inovalon Revenue
Inovalon's revenue was reported to be $667.52 m in FY, 2020
| USD | |
|---|---|
Revenue (FY, 2020) | 667.5m |
Gross profit (FY, 2020) | 499.7m |
Gross profit margin (FY, 2020), % | 74.9% |
Net income (FY, 2020) | 22.6m |
EBIT (FY, 2020) | 71.7m |
Market capitalization (12-Nov-2021) | 3.1b |
Closing stock price (12-Nov-2021) | 40.8 |
Cash (31-Dec-2020) | 123.9m |
EV | 4.0b |
Inovalon's current market capitalization is $3.1 b.
Annual
Quarterly
| USD | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 117.6m | 105.5m | 102.7m | 123.8m | 105.0m | 108.3m | 110.6m | 115.9m | 92.8m | 152.8m | 145.8m | 145.5m | 157.0m | 166.5m | 154.2m | 162.2m | 161.4m | |
Cost of goods sold | 33.6m | 38.4m | 41.9m | 43.2m | 35.4m | 38.3m | 37.2m | 38.4m | 33.5m | 39.0m | 36.4m | 37.2m | 41.1m | 42.9m | 41.0m | 36.8m | 39.6m | |
Gross profit | 84.0m | 67.1m | 60.7m | 80.6m | 69.6m | 70.0m | 73.4m | 77.4m | 59.3m | 113.8m | 109.4m | 108.3m | 115.9m | 123.5m | 113.1m | 125.5m | 121.8m | |
Gross profit Margin, % | 71% | 64% | 59% | 65% | 66% | 65% | 66% | 67% | 64% | 74% | 75% | 74% | 74% | 74% | 73% | 77% | 75% |
Annual
Quarterly
| USD | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash | 793.1m | 194.4m | 166.5m | 126.9m | 159.8m | 214.4m | 147.9m | 192.0m | 232.6m | 410.0m | 68.0m | 103.5m | 119.9m | 129.9m | 133.6m | 182.9m | 95.6m | 120.1m |
Accounts Receivable | 65.6m | 87.0m | 93.5m | 73.2m | 94.8m | 79.9m | 101.6m | 95.7m | 83.8m | 78.4m | 114.1m | 110.0m | 117.4m | 115.4m | 127.4m | 129.1m | 132.3m | 130.6m |
Prepaid Expenses | 5.7m | 7.5m | 16.7m | 21.2m | 17.1m | 8.8m | 13.0m | 10.9m | 11.7m | 14.2m | 18.0m | 21.4m | 20.4m | 21.3m | 20.6m | 24.6m | 23.0m | 23.2m |
Current Assets | 865.0m | 891.9m | 848.6m | 850.1m | 865.7m | 813.8m | 660.6m | 645.9m | 625.3m | 554.7m | 228.7m | 257.3m | 267.1m | 272.3m | 287.0m | 344.6m | 257.9m | 287.8m |
Annual
Quarterly
| USD | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 13.8m | 39.9m | 50.0m | 2.4m | 18.6m | 26.4m | 3.6m | 9.1m | 17.4m | (16.8m) | (27.3m) | (28.1m) | (8.3m) | (3.8m) | 3.1m | (1.7m) | 342.0k | 1.2m |
Depreciation and Amortization | 4.9m | 9.7m | 15.3m | 8.4m | 16.9m | 25.8m | 12.5m | 25.0m | 38.5m | 16.4m | 43.3m | 69.9m | 27.0m | 54.5m | 81.4m | 27.9m | 58.6m | 86.7m |
Accounts Payable | (1.7m) | (139.0k) | 4.9m | (2.2m) | (7.7m) | (5.9m) | 69.0k | 5.7m | 5.7m | (1.7m) | (10.7m) | (5.4m) | 182.0k | 2.4m | 1.5m | (2.8m) | 3.6m | 4.3m |
Cash From Operating Activities | 817.0k | 19.7m | 44.2m | 14.3m | 32.4m | 68.6m | 2.3m | 41.1m | 80.9m | 6.9m | 20.1m | 63.0m | 14.8m | 39.9m | 72.3m | 14.1m | 63.1m | 109.1m |
Inovalon Acquisitions / Subsidiaries
| Company Name | Date | Deal Size |
|---|---|---|
| ABILITY Network | March 07, 2018 | $1.2 b |
| Amphenol FCI Besancon SA |
Inovalon Cybersecurity Score
Inovalon Environment, Social & Governance (ESG) Ratings
Inovalon Online and Social Media Presence
1.5k Twitter followers
Inovalon has 1.5k Twitter Followers. The number of followers has increased 0.4% month over month and increased 0.5% quarter over quarter
Inovalon's Trends
Twitter Engagement Stats for @InovalonInc
3.5k
Tweets
648
Following
1.5k
Followers
19
Tweets last 30 days
0.1
Avg. likes per Tweet
26.3%
Tweets with engagement
Inovalon Company Culture
Overall Culture
B+
76/100
CEO Rating
B
73/100
Compensation
C+
66/100
Diversity
C+
68/100
Inovalon News and Updates
May 12, 2022
CorEvitas, LLC and Inovalon Highlight Data Linkage Efficiencies at ISPOR
Panelists explore how connecting claims and clinical registry data lead to a better understanding of the patient journey WALTHAM, Mass. and BOWIE, Md., May 12, 2022 /PRNewswire/ -- CorEvitas, LLC, the built-for-purpose provider of real-world evidence, and Inovalon, a leading provider of...
March 29, 2022
American Oncology Network Taps Inovalon to Support Efficient, Reliable Delivery of Oral Oncology Medications
ScriptMed® Cloud will Support Specialty Pharmacy Services and Monitoring of Oral Oncology Medications to Help Improve Clinical and Quality Outcomes for Patients ScriptMed® Cloud will Support Specialty Pharmacy Services and Monitoring of Oral Oncology Medications to Help Improve Clinical and Quality …
March 14, 2022
Pharmacare Hawaii Selects Inovalon to Ensure Best Clinical Outcomes for Specialty and Infusion Pharmacy Patients
ScriptMed® Cloud Provides Access to Data and Tools to Ease Referral Management and Guide Patient Insight and Intervention to Ensure Safety, Adherence, and Improved Outcomes
March 14, 2022
Inovalon Launches Registration Assurance Solution for Healthcare Providers
Newest Provider Offering Improves Patient Experience, Registration Speed, and Coverage Accuracy, Reducing Coverage-Related Revenue Losses Newest Provider Offering Improves Patient Experience, Registration Speed, and Coverage Accuracy, Reducing Coverage-Related Revenue Losses
March 07, 2022
Inovalon Launches Industry’s First Converged Risk Adjustment and Quality Measurement Analytics SaaS Solution
With The Inovalon Converged Solution, Health Plans Can More Efficiently and Effectively Predict and Resolve Comprehensive Care Needs for Members at an Individual, Cohort, or Plan Level With The Inovalon Converged Solution, Health Plans Can More Efficiently and Effectively Predict and Resolve Compreh…
January 26, 2022
Value Specialty Pharmacy Selects The Inovalon ONE® Platform’s Leading SaaS Capabilities
Innovative Specialty Pharmacy Leader to Implement ScriptMed® Cloud to Improve Clinical Outcomes for Patients
Inovalon Blogs
October 31, 2018
Bright Health Selects the Inovalon ONE® Platform
Innovative Health Plan Implements Comprehensive Program Leveraging Data-Driven Insights to Improve Quality and Economic Performance
Bowie, Md. – October 31, 2018 – Inovalon (Nasdaq: INOV), a leading technology company providing advanced, cloud-based platforms empowering data-driven healthcare, toda…
October 23, 2018
Inovalon Clients Realize Significant Increases in CMS Star Ratings Compared to National Average For 5th Year In a Row
Advanced Analytics and Data-Driven Capabilities Powered by the Inovalon ONE® Platform Support Meaningful Quality Outcomes Improvements
Bowie, Md. – October 23, 2018 – Inovalon (Nasdaq: INOV), a leading technology company providing advanced, cloud-based platforms empowering data-driven healthcare, t…
September 10, 2018
How Health Plans Can Ensure a Successful Quality Season in 2019
Inovalon
Nearly 75% of Medicare Advantage (MA) enrollees were enrolled in plans rated at 4-Stars or higher in 2018, but the percentage of health plans that received a quality bonus for reaching four or five stars dropped from 49% to 44% — a decrease that may be cause for concern in light of the indu…
August 01, 2018
Keith R. Dunleavy, M.D.
Chief Executive Officer and Chairman of the Board
Dr. Dunleavy has served as Inovalon’s Chief Executive Officer since his organization of the company's predecessor companies in 1998, as Chairman of the board of directors since the creation of the board in 2006, and as President from the Company's fo…
July 26, 2018
Inovalon Achieves Significant Advancement In Cloud Computing Capabilities
Company Develops and Deploys Highly Elastic Cloud Container Orchestration Engine
Bowie, Md. – July 26, 2018 – Inovalon (Nasdaq: INOV), a leading technology company providing advanced, cloud-based platforms empowering data-driven healthcare, today announced that it has successfully developed and dep…
July 19, 2018
Home
http://www.inovalon.com/sites/default/files/press-releases/2018/alliancerx-walgreens-prime-selects-inovalon-one-platform-specialty-pharmacy.pdf/alliancerx-walgreens-prime-selects-inovalon-one-platform-specialty-pharmacy.pdf
https://abilitynetwork.com/…
Inovalon Frequently Asked Questions
When was Inovalon founded?
Inovalon was founded in 1998.
Who are Inovalon key executives?
Inovalon's key executives are Keith R. Dunleavy, Robert A. Wychulis and Eron S. Kelly.
How many employees does Inovalon have?
Inovalon has 2,371 employees.
What is Inovalon revenue?
Latest Inovalon annual revenue is $667.5 m.
What is Inovalon revenue per employee?
Latest Inovalon revenue per employee is $281.5 k.
Who are Inovalon competitors?
Competitors of Inovalon include Springbuk, Trellis Rx and Orion Health.
Where is Inovalon headquarters?
Inovalon headquarters is located at 4321 Collington Rd, Bowie.
Where are Inovalon offices?
Inovalon has offices in Bowie, Boston, Canonsburg, Minneapolis and in 4 other locations.
How many offices does Inovalon have?
Inovalon has 8 offices.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies